NCT05924789Completed
Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America
Source: ClinicalTrials.gov · Last updated 12 Feb 2025
Brief summary (registry, in English)
Currently, there is no Brazilian or Latin American epidemiological data, such as clinical-pathological characteristics, standard treatments and outcomes of gastric cancer and pancreatic cancer in the region. The study aims to create a Latin American multicenter database to analyze epidemiological, clinical, and pathological data, treatments, outcomes, and biological information from patients with gastric and pancreatic cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 120 (actual)
- First submitted
- 8 Mar 2023
- Start date
- 11 Aug 2023
- Primary completion date
- 24 Sept 2024
- Lead sponsor
- Latin American Cooperative Oncology Group
- NCT number
- NCT05924789
What you commit to
- Study type: Observational
- Participants enrolled: 120
- From 11 Aug 2023 to the primary completion date, 24 Sept 2024
- 6 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Synchronous invasive tumor or second primary tumor in the last three years (except thyroid tumors or non-melanoma skin);
- Nonepithelial histology in Cohort A: Sarcoma, GIST, lymphoma, and tumors of neuroendocrine origin;
- Nonepithelial histology in Cohort B: Sarcoma, GIST, lymphoma, pancreatoblastoma, and tumors of neuroendocrine origin.
Who the study is looking for
- ≥18 years
- Histological diagnosis of gastric and gastroesophageal junction cancer (Cohort A) or histological diagnosis of pancreatic cancer (Cohort B);
- Advanced disease diagnosis from January 2019: patients can be included prospectively. Advanced disease is defined as metastatic disease or locally advanced disease not amenable to curative therapy;
- Availability of adequate medical data for data collection.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto de Oncología San Gerónimo Coordinator of this site? Confirm its status | Santa Fe | Argentina | Unknown status |
| CEPON - Centro de Pesquisas Oncologicas Coordinator of this site? Confirm its status | Florianópolis | Brazil | Unknown status |
| HMV - Hospital Moinhos de Vento Coordinator of this site? Confirm its status | Porto Alegre | Brazil | Unknown status |
| ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Coordinator of this site? Confirm its status | Salvador | Brazil | Unknown status |
| A.C. Camargo Cancer Center Coordinator of this site? Confirm its status | São Paulo | Brazil | Unknown status |
| BP - A Beneficência Portuguesa de São Paulo Coordinator of this site? Confirm its status | São Paulo | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.